TORONTO, July 18, 2019 (GLOBE NEWSWIRE) -- Patriot One Technologies Inc. (TSX: PAT) (OTCQX: PTOTF) (FRANKFURT: 0PL) (“Patriot One” or the “Company”), developer of the PATSCAN™ Multi-Sensor Covert Threat Detection Platform (“PATSCAN”) reports that its business development team is...
Tailwinds' Take: with a small discount, this deal appears to be well received by the market. HYRE is in a land-grab for market share and these funds could really accelerate growth particularly if this is being used to roll...
Tailwinds' Take: if trends continue, the 90 day data should be very positive. We continue to believe that HJLI represents a compelling risk/reward scenario in which both products are exceeding expectations while the market cap of the Company remains...
Operator:Good day, everyone. Welcome to today’s corporate update and discussion of recent alliance with Cleveland Clinic on breast cancer vaccine. At this time, all participants are in a listen only mode. Later, you will have the opportunity to ask...
SAN JOSE, Calif., July 22, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today announced that it is partnering with the VA Maryland Health Care System's Baltimore VA...
Tailwinds' Take: this is potentially the most significant announcement in CATS' history. They are using their AI to expand their product line significantly. I suspect, from the language being used here, that we are closer than ever to national...
Last week, HYRE sold shares at $3. I have to admit, this came as a total surprise to me. With HyreCar going cash-flow neutral in the 2nd quarter, I had been operating under the assumption that they wouldn’t need...
SAN JOSE, Calif., July 24, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today announced that the United States Patent and Trademark Office (USPTO) has issued US...
Sometimes big news falls on deaf ears. Which, by the way, is one of the reasons I like the micro-cap space. With only a few analysts, if any, focused on a company, meaningful news can often be overlooked for...
TORONTO, July 25, 2019 -- Patriot One Technologies Inc. (TSX: PAT) (OTCQX: PTOTF) (FRANKFURT: 0PL) (“Patriot One” or the “Company”), developer of the PATSCAN™ Multi-Sensor Covert Threat Detection Platform (“PATSCAN”),  is pleased to announce that it has completed an exclusive global commercial...
ANDOVER, Mass., July 25, 2019 (GLOBE NEWSWIRE) -- Vicor Corporation (NASDAQ: VICR) today reported financial results for the second quarter and six months ended June 30, 2019.  These results will be discussed later today at 5:00 p.m. Eastern Time, during management’s quarterly investor conference call. ...
Tailwinds' Take: This data borderlines on perfect results as the only patient not showing normal reflux post surgery couldn't take anticoagulants. The VenoValve is poised to attract strong strategic interest as it moves into and through a pivotal trial....
Tailwinds' Take: this is the third VA hospital to join the Cchek study. This demonstrates the success the diagnostic must be showing in other hospitals and is a positive sign for obtaining CLIA approval sometime in the October time...
Tailwinds' Take: the HROW machine just keeps chugging along. Mayfield could be the most exciting spinoff yet, with multi-billion potential. The markets they're going after are large and unserved. Expect to hear about funding within a number of weeks,...
TORONTO, ON – July 31, 2019 – Patriot One Technologies Inc. (TSX: PAT) (OTCQX: PTOTF) (FRANKFURT: 0PL) (“Patriot One” or the “Company”), developer of the PATSCAN™ Multi-Sensor Covert Threat Detection Platform (“PATSCAN”),  is pleased to announce that it has signed...
Tailwinds' Take: add another subsidiary to the list of companies formed under the Harrow umbrella. Potential market of $2B they are looking to address. The good news just keeps coming... NASHVILLE, Tenn., Aug. 02, 2019 (GLOBE NEWSWIRE) -- Harrow Health,...
This past month is best described as tricky. July is often that way for investors. Volumes are light and traders tend to take time off before earnings season starts up. This results in volatility that, oftentimes in micro-cap companies,...
Tailwinds' Take: the key statement here is "Speakerless WiSA Ready TVs are anticipated to enter the market in 2020". WiSA is the best sound standard for home entertainment systems. With a 5% attachment rate to these 20 million WiSA...
Tailwinds' Take: this is a positive endorsement of RESN's technology. The stock should respond well. However, it's a stop-gap until the next round of financing, which is likely to occur later this year. Until we see revenue traction, our...
NEW YORK, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announces the acquisition of Daxor's BVA-100 blood volume analyzer as part of standard...
GOLETA, CA / ACCESSWIRE / August 6, 2019 / Resonant Inc. (NASDAQ:RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for mobile handset and wireless devices, today provided an update on its...
Tailwinds' Take: MTBC is becoming a little cash cow. While not wild about the core business, we have a ton of respect for management and the job they are doing in this space. Expect them to announce another acquisition...
MEDFORD, N.Y., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc.(Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial results for the quarter ended June 30, 2019. Recent Accomplishments & Highlights Achieved total revenue of $9.6 million for the second quarter...
Tailwinds' Take: while not official "guidance", the Company obviously believes that their products will generate substantial revenue and cash flow in 2020 and beyond. With a market cap under $20M, the stock trades at less than 1/2 the total...
You gotta love Resonant. It seems like every quarter the Company misses earning projections, yet dangles a carrot so delicious that investors get distracted. Shorts have reason to feel good, so do the bulls. RESN is a great battleground...
Tailwinds' Take: great incremental growth. LOS ANGELES, Aug. 07, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) today reported second quarter 2019 financial results. “We successfully continue to build our global TRU NIAGEN brand and consequentially had another quarter strengthening our business...
LOS GATOS, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Atomera Incorporated (NASDAQ: ATOM), a semiconductor materials and intellectual property licensing company focused on deploying its proprietary technology into the semiconductor industry, today provided a corporate update and announced financial results for the second...
NEW YORK, Aug. 08, 2019 (NewMediaWire) -- PeerStream, Inc. (“PeerStream,” the “Company,” “we,” “our” or “us”) (OTCQB: PEER), a communications software innovator developing enhanced security and privacy solutions for multimedia communication and data transmission, today announced financial and operational results...
Atomera (ATOM) reported earnings on Wednesday after the close. The numbers are rather meaningless for Atomera as they are pre-revenue. What investors are looking for is clues to when revenues will start and the likelihood that customers will adopt...
This was a very hectic week in the market, with major swings in the indexes and in our universe of smaller companies. Earnings season for most smaller companies is the first two weeks of August, which creates ample reasons...
Tailwinds' Take: another solid report from CYRX. The stock remains expensive, but the moat is huge and the growth is great, so don't be scared by the valuation.  IRVINE, Calif., Aug. 8, 2019 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW)...
~ Trade alerts discuss changes to Tailwinds' managed portfolios. They are available for premium subscribers only. The information contained here is not meant to be shared, especially with Company managements. Thank you. ~ We have sold our position in Resonant...
Tailwinds' Take: this expansion should easily bring their eligible lives to well over 100,000. It also demonstrates that the program is working as Aetna continues to expand their involvement. The investor update call on Wednesday could really send shorts...
Tailwinds' Take: Dyadic is executing on their vision, with the proof being the number of research partnerships they are signing. DYAI remains a very inexpensive bet on a potentially massive market-changing opportunity. JUPITER, FL / ACCESSWIRE / August 13, 2019...
Tailwinds' Take: continued strategic interest in CDXC bodes well for future market acceptance of Tru Niagen. Revenues beat last Q and are in a very high growth mode. More clinical validation coming will continue to support the high valuation...
Tailwinds' Take: more excellent results for this product. It's several years from market, but the data so far suggests it could be on a smooth path through the FDA and the end market is potentially in the billions with...
Tailwinds' Take: it's all about consumer uptake now. We are at the inflection point in revenue. Will be an interesting next few months. SAN JOSE, Calif.--(BUSINESS WIRE)-- Summit Wireless Technologies, Inc. (NASDAQ: WISA), a leading provider of immersive, wireless sound technology for intelligent...
NASHVILLE, Tenn., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today reported results for the second quarter 2019. Second Quarter 2019 and Other Recent Notable Highlights: 46% year-over-year increase in ImprimisRx ophthalmology gross revenue to $12.1 million ...
Tailwinds' Take: solid growth, although shy of the Street forecasts. Guidance, as always, very strong. Conference call will determine near-term direction. Longer-term, things look great. LOS ANGELES--(BUSINESS WIRE)--Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled...
Shares of Summit Wireless (WISA) have been savaged over the last year. Since their IPO all of 14 months ago, the stock has collapsed 80%, recently trading below $1. There are reasons why the stock has been weak, however,...
Shares of Catasys (CATS) are down over 15% as I write this article. Trading at close to $15 a share, the stock has retreated over 25% from the recent 52 week highs that it hit a few months ago. This...
Tailwinds' Take: great news for Patriot One. Johnson Controls is an international behemoth and this release both endorses the PATSCAN platform and opens up a ton of potential sales opportunities. TORONTO, ON – August 15, 2019 -- Patriot One Technologies Inc. (TSX:...
~ Trade Alerts are sent to premium subscribers in real time. This alert was sent out yesterday, however I feel it should be shared more broadly as it contains important information on Harrow. ~ Shares of HROW are down significantly...
The path to being a good investor is to be able to see what the future holds and place your bets accordingly. If you can do so often, you'll have a portfolio of winners. It's an easy game, right? There...
Tailwinds' Take: we are getting closer towards the crucial data point of 6-month data which will be in October. That is likely the catalyst to spark the medical community's interest; success in the science will drive success in the...
GUILFORD, Conn.–(Business Wire)– Bioasis Technologies, Inc . (OTCQB:BIOAF; TSX.V:BTI), (the “Company” or “Bioasis”), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 TM platform technology for the delivery of therapeutics across the blood-brain barrier (“BBB”) and the treatment of central nervous system...
Quite often when I write about companies I'm just about the only one doing so. It's in these situations that Tailwinds can add value by not only highlighting our investment thesis, but in educating investors about a company in...
~ Trade alerts discuss changes to Tailwinds' managed portfolios. They are available for premium subscribers only. The information contained here is not meant to be shared, especially with Company managements. Thank you. ~ We have initiated a position in Mogo,...
Tailwinds' Take: Elias chaired a group at the conference and kicked off the panel by presenting the VenoValve. Having spoken multiple times with Dr. Elias, I can say that he started off pretty skeptical on the product and seems...
Much of the analysis and forecasting work that I do on the markets revolves around the S&P 500 Index, the basket of 500 blue chip larger cap companies widely followed. The reason being is that index has quite a...
Today was the LD Micro SF Summit. As Chris Lahiji said, 27 companies, 27 investors. We all sit around the table and they bring them through one after another for roundtable discussions. It made for a very long, but...
We are pleased to have had the opportunity to interview Bill Kerby, the CEO of Monaker Group. Tailwinds recently initiated coverage on Monaker and our overview is available here. Tailwinds Research (TW) - As this is our first CEO interview,...
Recently the Centers for Medicare & Medicaid Services ("CMS") issued an update to the Hospital Outpatient Prospective Payment System. This updated guidance, that has an effective date of October 1, 2019, provided clarification on guidance for intraocular or periocular...
NEW YORK, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, filed a Form N-CSR disclosing its schedule of portfolio holdings as of June 30,...
SOMERSET, N.J., Sept. 05, 2019 (GLOBE NEWSWIRE) -- MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of proprietary, cloud-based healthcare IT and revenue cycle management solutions, announced that Medi-Weightloss Franchising, USA, LLC, a premier national medical weight loss provider has...
I’ve held off on my August recap much like a war veteran will refrain from telling tales from the trenches. Not that my experiences are nearly as terrible as a real war, but in the figurative sense, August left...
Tailwinds' Take: while there is no one technology that is the key to security, integrating multi-sensor technology and using Artificial Intelligence to assist in threat detection can bring performance of a system like PATSCAN to levels much higher than...
HyreCar has been public for only a little over a year. During that time the platform has grown dramatically in volumes, while improving gross margins. Sales are trending towards close to doubling for the year and, with the completion...
Tailwinds' Take: Nice to see this patent as it shows they continue to make progress behind the scenes, despite their noticeable lack of marketing around the company and its shares.  Guilford, CT. Bioasis Technologies, Inc. (OTCQB:BIOAF; TSX.V:BTI), (the “Company” or...
Having covered Resonant for several years now, I’ve roundtripped the stock a few times. It has gone from $2 to $8 and then back and forth several times. The journeys higher have always been driven by success in both...
I’m a big fan of Alternative Lodging Rentals (ALR). Having a large family that is now spread out around the country, when we travel we like to stay in one location. Hence, renting a house or apartment has become...
Tailwinds' Take: it's very telling that Cisco brought Patriot One into this project. This demonstrates their confidence in the technology and is a great sign that, once it's commercially deployed, Cisco will be a great sales and distribution channel. TORONTO,...
Tailwinds' Take: adding to the team at a time where the biggest question mark is financing says that management isn't concerned about funding. Volumes are ramping now and the rollout is starting. WISA represents a great play on what...
Tailwinds' Take: The Lasker Award is a big honor and demonstrates the strength of Anixa's scientific board. Dr. Shepard's work in breast cancer has direct applicability to Cchek's efforts in that space. SAN JOSE, Calif., Sept. 16, 2019 /PRNewswire/ -- Anixa...
Tailwinds' Take: Two seasoned executives filling the open board seats is a positive event for HJLI. The street is still awaiting the 6 month data due out in October, which should be the big catalyst for the stock and...
Now that the summer is over, and the fall conference season is ahead I thought it might be a good time for an interview with Dr. Amit Kumar, CEO of Anixa, for an update on their programs. With several...
Investors in Patriot One (PAT) have been waiting for revenues to kick in for a while. This is not without just cause as the launch of the original PATSCAN product was supposed to have occurred over a year ago....
Tailwinds' Take: endorsement from KOL's like the Potomac Urology Center is key to getting Cchek broad acceptance and a maximum valuation when they eventually partner with a large national lab sometime in the next year or so. SAN JOSE, Calif.,...
Tailwinds' Take: PRVB finally ripped the bandaid off and raised this money. A couple key takeaways. The headline says $40 million, but the total was $60 with Amgen providing $20 million on the same terms. A very positive...
I tend to be very much a buy and hold investor. I take positions, add to them as I gain confidence and generally let them ride. I do add to stocks on weakness and will trim some into strength....
Tailwinds' Take: this is very big news for several reasons. Goldman is a very high quality lender who can obviously get much larger in size as Catasys grows. Their due diligence prior to making this loan is an endorsement...
OLDWICK, N.J., Sept. 24, 2019 /PRNewswire/ -- Provention Bio, Inc., (Nasdaq: PRVB), a clinical-stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today reiterated its regulatory strategy regarding PRV-031 (teplizumab) for the prevention or delay of clinical type...
GUILFORD, Conn.–(Business Wire)– Bioasis Technologies, Inc . (OTCQB:BIOAF; TSX.V:BTI), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 TM platform technology for the delivery of therapeutics across the blood-brain barrier (“BBB”) and the treatment of central nervous system (“CNS”) disorders in areas...
Tailwinds' Take: this is a very high quality addition to the board and lends a ton of credence to their diabetes programs. OLDWICK, N.J., Sept. 26, 2019 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a clinical stage biopharmaceutical company dedicated to...
~ Trade alerts discuss changes to Tailwinds' managed portfolios. They are available for premium subscribers only. The information contained here is not meant to be shared, especially with Company managements. Thank you. ~ I have reduced our position in Catasys...
On Tuesday Catasys (CATS) announced that their long-awaited lending partner is none other than Goldman Sachs. We believe this is a very positive development for Catasys as it removes the financing overhang from the stock and provides them with...

Ciao!

In Italy, the word Ciao is a salutation for both hello and goodbye. It's appropriate for this week's newsletter as, while you're reading this, I'll be en route to Italy. Ciao Italia! Of course, if you're reading this at your...
“The total decoupling of U.S. and China technologies is not possible…After all, we will know what these American scientists are doing if they release their research in the internet age. They can never live in the refrigerator.” Huawei CEO Ren...
Tailwinds' Take: great news as the rollout of Wisa is starting here and now. Q4 should be very exciting for WISA. SAN JOSE, CA (October 1, 2019) – WiSA® LLC, the Wireless Speaker and Audio Association, comprised of over 60...
Tailwinds' Take: while this news is expected, it is still a positive, especially as shorts had been saying it might not close. That being said, the question for RESN is, "what next?" We expect revenues to continue to be...
Greetings from Stresa Italy, a gorgeous town on the edge of Lake Maggiore. With great food, excellent wines and friendly people, Italy is always a great place to relax. This is especially true during times of market weakness, as...
Tailwinds' Take: as WISA nears its inflection point in terms of revenue generation, this non-dilutive financing will provide them with 9 months of cash on the balance sheet. This will enable the Company to show the market the traction...
Tailwinds' Take: the key takeaway from this is that the top scientists in the world are now coming on board to work with Anixa. Dr. Frazer is credited with enabling the creation of the first and only cancer vaccine...
Tailwinds' Take: not a moment of shining glory for the court system. This whole case is an ongoing fiasco that is just wasting dual resources of time and money. For a good take on it, go to www.rightofassembly.org. Eventually...
Going into writing this week's newsletter, I had no idea where to go with it. There's a lot happening in the world, a lot going on in micro-cap, and a lot churning around inside my head. The point being...
~ Trade alerts discuss changes to Tailwinds' managed portfolios. They are available for premium subscribers only. The information contained here is not meant to be shared, especially with Company managements. Thank you. ~ I have been increasing my holding in...
Tailwinds' Take: hiring an executive to lead business development is key for Cchek as Anixa will be looking to move the product onwards towards a national diagnostic lab company sometime during 2020. SAN JOSE, Calif., Oct. 15, 2019 /PRNewswire/ -- Anixa...
Tailwinds' Take: Sikora brings a very impressive resume to Monaker. The fact that someone with his background would leave a company like Boeing to join MKGI speaks volumes to the size and scale of the opportunity in front of...
GOLETA, CA / ACCESSWIRE / October 15, 2019 / Resonant Inc. (Resonant), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for mobile handset and wireless devices, announced that it has received the...
Today was a big day for Summit Wireless (WISA) on two fronts. First off, they presented at the Microcap Rodeo in Austin. Lots of good information came from that conference, the highlights of which I'll share below. Secondly, and...
TORONTO, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Patriot One Technologies Inc. (PAT.TO) (PTOTF) (0PL.F) (“Patriot One” or the “Company”), developer of the PATSCAN™ Multi-Sensor Covert Threat Detection Platform, is pleased to announce the sale of its PATSCAN Multi-Sensor Covert Threat Detection...
GOLETA, CA – October 21, 2019 - Resonant Inc. (Resonant), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for mobile handset and wireless devices, announced that royalty unit volumes for the...
LOS ANGELES--(BUSINESS WIRE)--HyreCar Inc. (NASDAQ: HYRE), the carsharing marketplace for ridesharing, today reported that it has significantly expanded its available car inventory by onboarding two large multi-location dealerships. These dealer partners have collectively added more than 200 cars already...
On Monday morning, HyreCar (HYRE) put out a press release discussing the onboarding of two large multi-location dealers to their platform. This is obviously great news as the Company’s success is dependent upon adding new vehicles to the platform;...
Tailwinds' Take: this partnership with the market leader in connectivity in the travel industry is a game-changing event for MKGI. We should expect Monaker to gain almost immediate access to many thousands of travel agents and to see volumes jump...
Tailwinds' Take: With CLIA approval for Cchek in prostate cancer expected within weeks, Anixa is already moving forward on a second indication. The recent hire of a solid head of the diagnostics' area and the success they are showing...
Tailwinds' Take: This drug is rather meaningless to the PRVB story, which is all about Type 1 Diabetes at this time. I think there's a good chance Janssen repurchases it or they get a similar amount of money from...
Tailwinds' Take: with the data being released at a conference, one can assume that it will be positive; as all trial data has been to date. This is a big catalyst for sparking strategic interest and HJLI will be...
Tailwinds' Take: the endpoints for this trial, time to recurrence and volume removed, should be easy for a well-known drug like Terlipressin to achieve. Next step for BIVI is obtaining funding. Once funded, this could be one of the...
As we head into the home stretch of 2019 the market for microcap stocks seems to have turned around. This time last year it was decimation in my space. Twenty-nineteen was shaping up that way over the last three...
Tailwinds' Take: this long-awaited data came out better than anyone could have asked for. Not only demonstrating effectiveness, but improving in efficacy over time is phenomenal. HJLI still needs more capital, but, hopefully, these results will be enough to...
Tailwinds' Take: While this is not unexpected, PRIME designation is still good news for PRVB. We believe that, based on the stock's trading over the last few days, that a low has been put in place for Provention and...
Tailwinds' Take: the gating factor for Cchek obtaining CLIA approval is recording a sufficient quantity of samples. The data continues to be even better than seen in earlier trials and the value of this product (and the platform) is...
On Friday, my favorite little boom or bust biotech, Bioasis, reported their results. There is very little to learn from looking at the numbers; this is a tiny, pre-revenue company. However, in the MD&A section of the filing was...
Back in the days of VHS, we had a grand total of two movies in my house for several of my formative years. The Road Warrior and Trading Places. Featuring two of the all-time greats, Mel Gibson and Eddy...
Tailwinds’ Take: Dr. Ostuni joining the Scientific Advisory Board (SAB) of Anixa could have major significance to the Company. Investors should really start paying attention to the recent additions to the SAB as they are telling signals into the...
Tailwinds' Take: this long anticipated announcement really launches the formal rollout of WiSA to the masses. By partnering in Best Buy displays, LG and Klipsch are going to drive consumer adoption of what is the best technology for surround...
TORONTO, ON – October 28, 2019 (GLOBE NEWSWIRE) –– Patriot One Technologies Inc. (TSX: PAT) (OTCQX: PTOTF) (FRANKFURT: 0PL) (“Patriot One” or the “Company”), developer of the PATSCAN™ Multi-Sensor Covert Threat Detection Platform, will officially announce a new officer safety initiative...
Tailwinds' Take: PeerStream is making headway in their quest to provide services to the government. This is the first potential contract of many. Hopefully it's the start of a snowball effect as they have many tens of millions of...
Tailwinds' Take: Zubko is a great addition to the board with her proven experience building companies focused on digital innovation in the travel industry.  WESTON, FL – October 30, 2019 – Monaker Group, Inc. (NASDAQ: MKGI), a technology leader in...
LOS GATOS, Calif., Oct. 30, 2019 (GLOBE NEWSWIRE) -- Atomera Incorporated (NASDAQ: ATOM), a semiconductor materials and licensing company focused on deploying its proprietary technology into the semiconductor industry, today announced it has reached an agreement to license Atomera’s Mears Silicon Technology (MST) technology to a...
Yesterday Atomera held their quarterly earnings update call. Just prior to the call, they also announced a new customer license being signed. Normally, one would expect that a pre-revenue company signing a new licensee for the technology would be...
Tailwinds' Take: Harman's endorsement of WiSA carries more significance as they are owned by Samsung. If/when Samsung supports the standard, it's game over. SAN JOSE, Calif.--(BUSINESS WIRE)-- WiSA® LLC, the Wireless Speaker and Audio Association, comprised of over 60 leading consumer...
GOLETA, CA / ACCESSWIRE / November 4, 2019 / Resonant Inc. (NASDAQ:RESN) (Resonant), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for mobile handset and wireless devices, announced that it is partnering...
Tailwinds' Take: with ANIX ready to file an IND within weeks, this patent helps secure their IP around a very promising potential cure for breast cancer. If the IND is approved, initial safety data will be available from an...
HyreCar Inc. (HYRE), the carsharing marketplace for ridesharing, today reported financial results and provided a corporate update for the third quarter ended September 30, 2019. “HyreCar’s third quarter revenues grew to $3.7 million, even as we continued to improve and...
OLDWICK, N.J., Nov. 5, 2019 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a clinical stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today reported financial results for the third quarter ended September 30, 2019. "The PRV-031 program continues to build...
GOLETA, CA - November 5, 2019 - Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for mobile handset and wireless devices, today announced financial results for the...
As the stock market hits new highs on all the major indexes seemingly daily, it appears that the market has moved to a “risk on” scenario. This coming after a very tough August when things looked rather bleak. There...
NEW YORK - November 07, 2019 - PeerStream, Inc. (“PeerStream,” the “Company,” “we,” “our” or “us”) (OTCQB: PEER), a communications software innovator developing enhanced security and privacy solutions for multimedia communication and data transmission, today announced financial and operational results...
Tailwinds' Take: based on Q3 numbers as a run rate, this is a very inexpensive stock. SOMERSET, N.J., Nov. 06, 2019 (GLOBE NEWSWIRE) -- MTBC, Inc. (the “Company” or “MTBC”) (Nasdaq: MTBC) (Nasdaq: MTBCP), a leading provider of proprietary, cloud-based...
Santa Monica, CA – November 19, 2019 – Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced the appointment of Mr. Gustavo Giraldo to its Board of Directors, replacing Ms. Sharon...
Third Quarter 2019 Highlights vs. Third Quarter 2018 Strong growth in net sales to $12.1 million, improved gross margin, and significantly improved marketing efficiency year-over-year. TRU NIAGEN net sales of $9.7 million, an 11% increase sequentially and an 86%...
Tailwinds' Take: Continue to believe WISA is positioned as a disruptor in surround sound technology and eventually the vast majority of AV systems will be on their platform.  SAN JOSE, Calif.--(BUSINESS WIRE)-- Summit Wireless Technologies, Inc. (NASDAQ: WISA), a leading provider of...
JUPITER, FL / ACCESSWIRE / November 13, 2019 Dyadic International, Inc. ("Dyadic") (NASDAQ: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to accelerate development, lower production costs and improve the...
Tailwinds' Take: Q3 revenue was up over 100% year/year, however guidance for hitting $35 million in 2019 means that Q4 will be up 20% sequentially. This is massive growth and is a great segue into their $90 million guidance...
Harrow reported earnings on Wednesday, November 13th. They also, for the first time, published a shareholder letter. This letter tells the complete story of how their business is doing and also details the incredible sum of the parts value...
Tailwinds' Take: another high-quality launch under the WiSA brand. THX will help bring much more consumer visibility to the standard. The quality, simplicity and low price point combine to make WISA a compelling platform. SAN JOSE, Calif.--(BUSINESS WIRE)-- WiSA® LLC, the...
THE COLONY, Texas, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Quest Resource Holding Corporation (NASDAQ: QRHC) ("Quest"), a national leader in environmental reuse, recycling, and waste disposal services, today announced financial results for the third quarter ended September 30, 2019. Third...
GUILFORD, Conn.–(Business Wire)– Bioasis Technologies Inc. (TSX.V:BTI; OTCQB:BIOAF) (the “Company” or “Bioasis”), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3™ platform technology for the delivery of therapeutics across the blood-brain barrier (“BBB”) and the treatment of central nervous system...
Tailwinds' Take: HJLI is now positioned to apply to the FDA for their pivotal trial. The products continue to show amazing efficacy and the stock doesn't begin to reflect the value created by Dr. Glickman and his team. IRVINE, California.,...
The last couple weeks have seen a slew of earnings reports and, more importantly, investor update calls from companies in the Tailwinds Universe. Importantly for investors, the market has seemingly righted itself for the smaller companies as good news...
Tailwinds' Take: a system that brings immersive sound at the cost of a high-end soundbar? Amazing systems like this one from Enclave are why WiSA will take off as a standard over the next year. SAN JOSE, Calif.--(BUSINESS WIRE)-- WiSA® LLC,...
LA JOLLA, Calif., Nov. 19, 2019 (GLOBE NEWSWIRE) --  INmune Bio, Inc. (NASDAQ: INMB), an immunology company developing treatments that harness the patient’s innate immune system to fight disease, today announced that Marcia Allen has joined the company’s board as...
IRVINE, California., November 19, 2019 – Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today  that Dr. Jorge Hernando Ulloa, the Principal Investigator for HJLI’s VenoValve study in...
~ Trade alerts discuss changes to Tailwinds' managed portfolios. They are available for premium subscribers only. The information contained here is not meant to be shared, especially with Company managements. Thank you. ~ Two trades over the last couple days. We...
Tailwinds' Take: there is some momentum building behind Cchek as partners are signing on rapidly. Once it's approved, groups like this will turn into early adopters and advocates of the product. SAN JOSE, Calif., Nov. 26, 2019 /PRNewswire/ -- Anixa Biosciences,...
Tailwinds' Take: key sentence here is from Dr. Kumar's quote, "commercial launch later this year." SAN JOSE, Calif., Nov. 20, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight...
LOS ANGELES, Nov. 20, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) today announced that European Member States have voted in favor of listing Nicotinamide Riboside Chloride (NR) as a novel food ingredient at a daily serving of 300mg for...
IRVINE, California, December 20, 2019 – Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today that an abstract entitled Results of First-in-Human Implantation of a Prosthetic Venous Valve...
Tailwinds' Take: we continue to believe that video gaming is going to be a huge market for WiSA products in the near future. SAN JOSE, Calif.--(BUSINESS WIRE)-- WiSA® LLC, the Wireless Speaker Audio Association, founded by Summit Wireless Technologies, Inc. (NASDAQ: WISA), today...
SAN JOSE, Calif., Nov. 22, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced a collaboration with Urology Centers of Alabama (UCA) in the...
Those who know me well are well aware that Wednesdays are my favorite night of the week. That's the night I go out mountain biking with The Gestalt Haus Gang, ending up at a similarly-named (mountain) biker bar tipping...
Tailwinds' Take: RateGain (DHISCO) is really starting to position for growth and to be the player in the vacation Rental space. See their press release below. Monaker, and its MBE, are the exclusive ALR/VR inventory provider and Booking Engine...
LA JOLLA, Calif., Nov. 26, 2019 (GLOBE NEWSWIRE) -- -- INmune Bio, Inc. (NASDAQ: INMB), an immunology company developing treatments that harness the patient’s innate immune system to fight disease, announced today its will host a live webinar on...
Tailwinds' Take: this trial looks poised for success as XPro1595 is known to be safe and reduce inflammation, the endpoints for this trial design.  LA JOLLA, Calif., Dec. 02, 2019 (GLOBE NEWSWIRE) --  INmune Bio, Inc. (NASDAQ: INMB), an immunology...
We are initiating coverage today on INmune Bio (Nasdaq: INMB). According to the Company, INmune (INMB) is “Reprogramming the Innate Immune System for the Treatment of Diseases”. On the surface, this sounds like a fairly standard biotech tagline, but...
Tailwinds' Take: Medeiros is a great hire for CATS. His resume is impressive and his experience meshes very well with the future envisioned by the Company. We are entering a very exciting stage of growth at Catasys, not only...
The name Tailwinds does not come, as is commonly assumed by many readers, from my love of sailing. An understandable assumption, based on our sailboat logo, but the reality is I get seasick the second I go below deck...
Tailwinds' Take: the science behind XB3™ appears to be very interesting to the medical community. Hopefully this translates into some strategic partnerships soon. GUILFORD, Conn.–(Business Wire)– Bioasis Technologies, Inc. (OTCQB:BIOAF; TSX.V:BTI), ), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3™ platform...
SAN JOSE, Calif., Dec. 13, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced that it will hold a conference call on December 17, 2019...
The market seems took a little hit this week, then bounced back. The net result of which was the wind coming out of the recent micro-cap rally. This is likely a temporary setback as valuations remain much cheaper and...
The other day a reader was kind enough to send me a video of a terrific interaction between two hedge fund legends.  Last month, Ray Dalio and Paul Tudor Jones sat down at the Greenwich Economic Forum to discuss a variety...
Tailwinds' Take: this is exciting news for BioVie. If BIV201 gets approved, one can assume the drug will gain fairly quick and broad acceptance not only for efficacy but cost savings reasons. The next step for the Company remains...
SAN DIEGO, Dec. 10, 2019 (GLOBE NEWSWIRE) -- ImprimisRx, the nation’s leading ophthalmic-focused outsourcing facility and pharmaceutical compounding business, a wholly-owned subsidiary of Harrow Health, Inc. (NASDAQ: HROW), announced that on December 9, 2019, its FDA-registered 503B outsourcing facility...
Tailwinds' Take: while expected, this is great news for Provention. The potential market for this drug is in the billions of dollars and the valuation is crazy cheap based on expected approval and sales. We expect them to partner...
Tailwinds' Take: as a leader in home control, Savant is incorporating WiSA into a total home package; a trend we expect to continue across multiple product lines. SAN JOSE, Calif.--(BUSINESS WIRE)-- WiSA® LLC, the Wireless Speaker and Audio Association, comprised of...
Tailwinds' Take: in my conversations with Dr. Kumar, I got the sense that the clinical team thought the product was ready to go into patients. But, the lead scientist has final say and his thoughts were that, although the...
~ Trade alerts discuss changes to Tailwinds' managed portfolios. They are available for premium subscribers only. The information contained here is not meant to be shared, especially with Company managements. Thank you. ~ I'm intending to make several trades over...
This morning Anixa (ANIX) announced the delay of their intended IND filing for a novel CAR-T therapy targeting ovarian cancer. This delay is likely to cost the Company up to a year on the filing and is a significant...
LA is usually a great place to be in December, compared to the rest of the nation. With the weather being generally sunny and mild, it's the perfect place for a conference. The last few years, having brought both...
Tailwinds' Take: very positive news as Anixa has Anixa launches what could be, over time, a very disruptive diagnostic test. Tomorrow will see the Company host a corporate update conference call which will provide more details on not only...
~ Trade alerts discuss changes to Tailwinds' managed portfolios. They are available for premium subscribers only. The information contained here is not meant to be shared, especially with Company managements. Thank you. ~ A few more changes to the portfolio...
Tailwinds' Take: support from a market leader like LG shows the disruptive nature of WiSA. CES is shaping up to be a very big deal for Summit Wireless. San Jose, CA -- (December 17, 2019) – WiSA® LLC, the Wireless...
Tailwinds' Take: "significantly increasing our outreach pool". That about sums up this press release. Catasys is likely to exceed 2020 guidance and continue expanding rapidly beyond then. Santa Monica, CA - December 17, 2019 -Catasys, Inc. (NASDAQ: CATS) ("Catasys" or...
Tailwinds' Take: this is a very positive step for this platform. Next steps here are to start a Phase IIa open-label trial next summer, with expected results about 12 months after dosing patients. Herceptin is a relatively uncrowded space...
New York - (NewMediaWire) - December 17, 2019 - PeerStream, Inc. (“PeerStream,” the “Company,” “we,” “our” or “us”) (OTCQB: PEER), a communications software innovator developing enhanced security and privacy solutions for multimedia communication and data transmission, today announced that...
When I first got involved with Patriot One (PAT), the story was very simple. They had a product, the Cognitive Magnetic Radar (CMR), that was going to be capable of screening for concealed weapons. Similar to a metal detector,...
Please click on the link below to see the complete transcript from Anixa's Investor Update conference call of December 17th, 2019. ANIXA_12172019 transcript
SAN JOSE, Calif., Dec. 23, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced that its chief executive officer, Dr. Amit Kumar, will present...
Tailwinds' Take: this deal demonstrates the effectiveness of FBIO's business model. They are accumulating a plethora of interesting drugs under their umbrella.  NEW YORK, Dec. 23, 2019 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”) today announced that Baergic...
Tailwinds' Take: needed financing to keep things going until they can land a strategic investor. The clock is ticking on my ability to hold this any longer. I'm expecting a bounce in early 2020 and, if they don't close...
Lots going on in Tailwinds' universe recently. Here I recap conversations and observations from the prior week's trading... This screen shot says it all...if Druck loves small cap, then I'm saying we're in the right space at the right time. HyreCar...
What a difference a year makes. Christmas 2018 marked a time of anguish for investors. The market was in the toilet and, for us small cap investors, it was particularly painful. There seemed to be zero bids out there...
This last week was actually a very good week for the Tailwinds' portfolio. Despite the overall quiet of a holiday week (or maybe because of it?), led by a 22% gain in Provention Bio, we managed to put up...
Tailwinds' Take: more solid data that should translate very well into humans. Remember, INmune has an ongoing Phase 1b trial in Alzheimer's Disease right now with results expected before the end of Q2. This data bodes well for those...
SAN JOSE, Calif., Jan. 6, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced that data from studies utilizing Cchek™, the company's artificial intelligence...
Tailwinds Take: the rate of adoption of Resonant's designs continues to be unimpressive. The key to this story remains 5G and that rollout is still a few years away from their perspective. We remain neutral on RESN until the...
Tailwinds' Take: this is potentially very big news. Sharp is now owned by Foxconn, the world's largest electronics manufacturing firm. Having them endorse speakerless TVs demonstrates that this trend is clearly going to happen and the WiSA platform will...
Tailwinds' Take: we expect the WiSA standard to make a big splash at CES2020. This is the future of home entertainment systems. LAS VEGAS--(BUSINESS WIRE)-- Consumer Electronics Show—WiSA® LLC, the Wireless Speaker and Audio Association, comprised of over 60 leading consumer...
In December of 2019, INmune Bio (INMB) commenced dosing of humans in a Phase 1b trial of XPro1595 (XPro), a drug targeting Alzheimer’s Disease. This trial is an 18 patient trial that is designed to run for 12 weeks...
Tailwinds' Take: Provention continues to build a team around the massive opportunity of tepluzimab. Hoitt has an impressive resume. We view his addition very positively. OLDWICK, N.J., Jan. 8, 2020 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a clinical stage...
Tailwinds' Take: this is outstanding news. Once again the science at HJLI is showing a dramatic divergence from the crazy-low valuation. After their funding issues are behind them, we expect to see the stock trading at a significantly higher...
SOMERSET, N.J., Jan. 08, 2020 (GLOBE NEWSWIRE) -- MTBC, Inc. (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of cloud-based healthcare IT and revenue cycle management solutions, today announced the closing of its acquisition of CareCloud Corporation, (“CareCloud”) which provides its proprietary,...
Technological progress benefits all of humanity in terms of lifespans and health, the ability to travel and communicate—the whole cornucopia of goods and services that have become increasingly available in the last five hundred years. The rise of the...
Tailwinds' Take: Journey is growing rapidly as they execute on the overall strategy of FBIO; licensing low-risk products and bringing them to market. This story is just in the early stages. SCOTTSDALE, Ariz., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Journey...
Tailwinds' Take: the many shots on goal under the FBIO umbrella is one of the most compelling aspects of the company. This is great news from CKPT, of which FBIO is a very large shareholder. The sum of the...
Tailwinds' Take: as we anticipated, revenue re-accelerated in Q4. 2020 is looking to be a solid year for HYRE as their OEM and dealer partners continue to move forward with increasing cars on the service. LOS ANGELES--(BUSINESS WIRE)--HyreCar Inc. (NASDAQ:...
GOLETA, CA / ACCESSWIRE / January 13, 2020 / Resonant Inc.(NASDAQ:RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for mobile handset and wireless devices, today announced its RF filter design innovation that...
Tailwinds' Take: This guidance puts MTBC at around 6 times 2020 EBITDA. Growth by acquisition is working well for these guys, who are excellent operators. Somerset, N.J., Jan. 13, 2020 (GLOBE NEWSWIRE) -- MTBC, Inc. (Nasdaq: MTBC) (Nasdaq: MTBCP), a leading provider...
Tailwinds' Take: we remain believers in Tru Niagen and think it has a bright future. When we think the company is financed through to cash-flow positive, that's when you back up the truck here. LOS ANGELES, Jan. 15, 2020 (GLOBE...
Tailwinds' Take: Fortress' value add is in finding underdeveloped drugs that have excellent scientific research and bringing them through the FDA process and to market. With 25 different programs, Fortress has many shots on goal and the sum of...
Tailwinds' Take: this is very interesting news. We have long stated our respect for Dr. Kumar. His ability to think outside the box is phenomenal and this program, with OntoChem demonstrates that thinking. OntoChem has the largest database of...
New Years always brings out the prognosticator in all of us. Everyone likes to predict what the market will do, what sectors will shine and their favorite stock for the coming 52 weeks. I'm no different, having given out...
Tailwinds' Take: more signed agreements show that RESN's products are gaining traction. However, the lengthy time to revenues and the large cash burn keep us on the sidelines for the time being. GOLETA, CA / ACCESSWIRE / January 22, 2020 /...
With a plethora of balls in the air, Fortress Biotech is a very difficult company to value. Their financials, being a combination of the multiple companies in which Fortress has a minority ownership yet a control position through their...
TORONTO, ON – January 23, 2020 (GLOBE NEWSWIRE) –– Patriot One Technologies Inc. (TSX: PAT) (OTCQX: PTOTF) (FRANKFURT: 0PL) (“Patriot One” or the “Company”), developer of the PATSCAN™ Multi-Sensor Covert Threat Detection Platform, is pleased to announce receipt of...
Tailwinds' Take: Eton is executing on their strategy as this announcement demonstrates that Biorphen is gaining traction in the market. We continue to believe owning Harrow (HROW) shares is the preferred way of playing Eton through their ownership stake, as Harrow...
On Thursday this week, as we finished dinner I looked out the window and the sky was on fire. It was quite possibly the most amazing sunset I've seen from our house and was a great way to end...
In investing there are some givens and some unknowns. The givens are the things that we know to be true. These drive investment themes and lead investors to look at individual sectors and specific companies. For example, we know...
I was skiing outside Seattle last weekend. Steven's Pass ski resort, to be precise. They have gotten a lot of snow up there this winter and the base was great. There was also a foot and a half of...
The disruptive forces of the internet, technology, streaming, and OTT services are well known. They have not only created new industries but forced existing entities to change their business models in order to survive. This is particularly true of...
VANCOUVER, British Columbia, Feb. 05, 2020 (GLOBE NEWSWIRE) -- Xtract Technologies Inc. (“Xtract.ai”), a subsidiary of Patriot One Technologies Inc. (TSX: PAT) (OTCQX: PTOTF) (FRANKFURT: 0PL), is pleased to announce it has secured a $975,000CAD Contract with Canada’s Department of...
Tailwinds' Take: these are important studies as they not only demonstrate the potential market size, but they show, very importantly, that testing can and will happen.  OLDWICK, N.J., Feb. 6, 2020 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a clinical...
Tailwinds' Take: we have been expecting this for a while. It probably marks a near-term low and might be a tremendous buying opportunity if the revenues finally start increasing. GOLETA, Calif. – February 6, 2020 – Resonant Inc. (NASDAQ: RESN),...
It's Oscar week right now and times they are a-changing. Netflix is up for numerous awards as they try to bludgeon their way into acceptance in Hollywood. They have certainly gained relevance, but will they win over the Old...
Tailwinds' Take: yet another disease where neuro-inflammation plays a role. The breadth of potential treatments for this product is staggering. LA JOLLA, Calif. , Feb. 10, 2020 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB), an immunology company developing treatments...
SAN JOSE, Calif.--(BUSINESS WIRE)-- Summit Wireless Technologies, Inc. (NASDAQ: WISA), a leading provider of immersive, wireless sound technology for intelligent devices and next-generation home entertainment systems and founding member of the WiSA Association, announced the appointment of Rob Tobias, 55, to...
Tailwinds' Take: this is exciting news for HYRE. Clutch is a strong partner with over 200 rooftop dealerships. More importantly, they are owned by Cox Automotive, who has 3,800 dealerships and over 40,000 dealership clients through their network. Cox...
Tailwinds' Take: our thesis remains that WiSA is best in class technology for combining audio with your home entertainment system. Thus, every speaker company will eventually adopt the standard or get left behind. SAN JOSE, Calif.--(BUSINESS WIRE)-- Summit Wireless Technologies, Inc. (NASDAQ:...
SOMERSET, N.J., Feb. 11, 2020 (GLOBE NEWSWIRE) -- MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of proprietary, cloud-based healthcare IT and practice management solutions today announced the rollout of its Group Purchasing Organization (“GPO”) and Release of Information (“ROI”) service...
Tailwinds' Take: this is very good news for Anixa as they remain on track for their IND filing. With the reformulation, ANIX is in a position to be the developer of what could be the first successful solid tumor...
LOS ANGELES, Feb. 12, 2020 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) today announced the launch of its flagship cellular health supplement Tru Niagen®  (nicotinamide riboside) as a supplement offering in Nestlé Health Science’s (NHSc) personalized nutrition service – Persona Nutrition. Persona...
R.J.: So, hello everybody, I'm R.J. Tesi. I'm the CEO and Acting Chief Medical Officer of Inmune Bio, and today I'll be hosting this bench to bedside, free, CTAD webinar highlighting alternative approaches to treatment of Alzheimer's disease....
LOS GATOS, Calif., Feb. 12, 2020 (GLOBE NEWSWIRE) -- Atomera Incorporated (NASDAQ: ATOM), a semiconductor materials and intellectual property licensing company focused on deploying its proprietary technology into the semiconductor industry, today provided a corporate update and announced financial results for the fourth...
Tailwinds' Take: Monaker's business launching with their partner RateGain appears to be increasingly a case of "when not if". I expect MKGI to be a big performer immediately post the announcement of their first bookings through the RateGain platform....
Tailwinds' Take: ATXI is one step closer to being acquired by Cipla. We believe FDA acceptance is a very likely outcome for IV Tramadol and continue to think that ATXI, and its parent FBIO, are not fully reflecting the...
Yesterday, Atomera provided investors with their quarterly update call. The stock had made a very large move prior to the call. If you recall on the last earnings call, they announced a new licensee for MST1 and suggested that...
Although I was aware of the trend towards E.S.G investing, I didn't understand the true magnitude of it until the recent action in Tesla.  Lots of people tell me that Tesla went up on its own and that E.S.G....
Tailwinds' Take: very exciting news for FBIO's 1/3 owned subsidiary, Mustang Bio. Expect to see the street taking targets up for MBIO, which is just another reason to own Fortress. NEW YORK, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Mustang Bio,...
Fortress Biotech (FBIO) has an interesting business model that involves an operating subsidiary focused on dermatology and multiple other partially owned subsidiaries that are independently managed and financed yet consolidated under their umbrella. Our first article on Fortress discussed...
SOMERSET, N.J, Feb. 18, 2020 (GLOBE NEWSWIRE) -- MTBC, Inc. (Nasdaq: MTBC) (Nasdaq: MTBCP), a leading provider of cloud-based healthcare IT and revenue cycle management solutions, today announced that NJ Spine and Wellness selected and has now gone live with CareCloud’s...
Tailwinds' Take: while this delays the approval, it's not a serious impediment and we still expect to see the NDA approved in 2020. Any associated weakness in HROW stock should be viewed as a buying opportunity. DEER PARK, Ill., Feb. 19,...
SOMERSET, N.J., Feb. 20, 2020 (GLOBE NEWSWIRE) -- MTBC, Inc. (Nasdaq: MTBC) (Nasdaq: MTBCP), a leading provider of cloud-based healthcare IT solutions and services, today announced the official formation of its telehealth division. MTBC also announced the appointment of the telehealth division’s...
This feels like a very strange time in the market. Usually markets overreact to news. Violent swings to extreme levels are the common occurrence around major market moving events. The coronavirus would appear to be one of these situations....
INmune Bio (INMB) is developing a drug targeting the innate immune system and, specifically, its role in the development of chronic inflammation as humans age. Their drug XPro1595 has recently entered a phase 1 trial; a trial that we...
Tailwinds' Take: share repurchases demonstrate the the company is fully funded and that they have high confidence in the current and future business. With acquisitions hopefully coming soon, I believe a share repurchase is an extremely positive indicator on...
Tailwinds' Take: if there was ever a situation tailored for a product, the CoronaVirus is the perfect scenario for Dyadic's C1 to shine. Let's hope they come up with a cure quickly for both the stock and, more importantly,...
Tailwinds' Take: really looking forward to seeing this data. All data to date has been unbelievably positive and no reason to think it won't continue on this trajectory. HJLI is poised to be a top performing stock for us...
Tailwinds' Take: this PR can be extrapolated into end market demand for WiSA systems doubling quarter over quarter here in early 2020. There will be an inflection point where everyone wants a WiSA system for their TV and, if...
As I look out my office window here in NorCal and see the blossoms on the tree, it's tough to remember that it's still winter for most of the country. The drought seems to have returned here which means...
Tailwinds' Take: this is great news for GRIL and, based on reading between the lines, one could guess this is likely CloudKitchen, which is Travis Kalanick's (UBER founder) newest venture they are partnering with. This deal alone ensures a...
Tailwinds' Take: we all know that CATS doesn't incorporate expansions into guidance, so this should give investors more confidence into their large growth expectations for 2020. It also demonstrates the value of their products to customers as expansions continue.  Santa...
Burleson, Texas, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Muscle Maker, Inc. (GRIL) today, Muscle Maker Grill announces its launch of their new Keto Your Way menu. The Keto Your Way menu was designed for customers who take part in a...
The last time we wrote about Vicor was almost a year ago (In Patrizio We Trust?). In that piece we discussed the Company’s history of missing guidance but that, “We believe management’s confidence will be well rewarded and are...
SOMERSET, N.J., Feb. 28, 2020 (GLOBE NEWSWIRE) -- MTBC, Inc. (the “Company” or “MTBC”) (Nasdaq: MTBC) (Nasdaq: MTBCP), a leading provider of proprietary, cloud-based healthcare IT solutions and services, today announced financial and operational results for the full year ended December...
Many times when I suggest that authorities will respond to this coronavirus situation with the MOAS (Mother Of All Stimulus), I get lectured how there is no way countries can stimulate because of; a) lack of fiscal room b) inability of different nations to...
When I first heard the name Muscle Maker Grill (MMG), I did a double check. The name seemed out of date with the times and I kept thinking of muscle-bound people drinking protein shakes. In all honesty, it took...
Tailwinds' Take: another solid hire as Catasys is planning on "hundreds of millions in revenue" over the next couple years. SANTA MONICA, Calif.--(BUSINESS WIRE)--Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced the appointment...
Tailwinds' Take: positive news as HROW's core business ramps in the stated direction of $100M in annual revenue. Expect a lot more catalysts for Harrow over the next few months. SAN DIEGO, March 03, 2020 (GLOBE NEWSWIRE) -- ImprimisRx, the...
With the market taking a further beating from CoronaVirus fears, we could all use a little good news. So, I'll enthrall y'all with the little bit of enjoyment in my life after another not so enjoyable week in the...
SAN JOSE, Calif., March 2, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced that data related to Anixa's recently launched Cchek™ Prostate Cancer...
Tailwinds' Take: Muscle Maker is executing on their strategy. Stay tuned for a lot more openings as this high-quality management team moves GRIL forward. Burleson, Texas, Mar. 3, 2020 - Muscle Maker, Inc. (Nasdaq: GRIL) owner of Healthy Joe's and...
Tailwinds' Take: once again, stellar scientific data presented on the VenoValve. The TAM is in the hundreds of millions with zero competition. HJLI represents an incredible valuation for groundbreaking technology. IRVINE, CA / ACCESSWIRE / March 5, 2020 / Hancock Jaffe...
Tailwinds' Take: the continued adoption of the WiSA platform is key for it to become an industry standard. We see more members of the WiSA association and, importantly, current members expanding the number of products offering WiSA. SAN JOSE, Calif.--(BUSINESS...
Vaccines seem to be all the rage these days. Well, at least ones related to the CoronaVirus. If you are somehow associated with the development of a COVID-19 vaccine or cure, your stock is strong and life’s good. If...
~ Akazoo trades at less than 1/3 Spotify’s EV to REV multiple ~ Growth of 50% in 2020 is double Spotify ~ Share repurchase coming soon This week saw Super Tuesday as Americans in 14 states came out to vote in the...
AUSTIN, Texas--(BUSINESS WIRE)-- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that the Company has engaged Torreya Partners, LLC (Torreya) to serve...
TORONTO, ON (March 9, 2020) – Patriot One Technologies Inc. (TSX: PAT) (OTCQX: PTOTF) (FRANKFURT: 0PL) (“Patriot One” or the “Company”), is pleased to announce it has been awarded a contract for the PATSCAN Multi-Sensor Covert Threat Detection Platform...
Tailwinds' Take: more good news for Harrow's ophthalmology division. Their core business continues to execute well. SAN DIEGO, March 09, 2020 (GLOBE NEWSWIRE) -- ImprimisRx, the nation’s leading ophthalmic-focused outsourcing facility and pharmaceutical compounding business, and a wholly-owned subsidiary of...
TFF Pharmaceuticals has much more promise than meets the eye. Upon inspection, their thin film freezing technology enables an improved drug delivery platform that could radically change how as much as 50% of drugs are prescribed.  The Power of Platform...
Tailwinds' Take: supporting Dolby Atmos means that WiSA speakers are not only the simplest surround sound solution, but deliver the most technologically advanced content. Further positioning themselves to be THE standard in home entertainment audio systems. SAN JOSE, Calif.--(BUSINESS WIRE)-- WiSA®...
Tailwinds' Take: their focus on the military is a nice niche and this program makes a lot of sense for building up that community's involvement. Burleson, Texas, Mar. 11, 2020 - Muscle Maker, Inc. (Nasdaq: GRIL) owner of Healthy Joe's...
Tailwinds' Take: with a pivotal trial ongoing, CKPT is another hidden gem in FBIO's vault. Funded through YE 2021 with hopes for BLA submission on Cosibelmab prior to then. NEW YORK, March 11, 2020 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc....
Tailwinds' Take: very positive results from this drug place PRVB in a great position of having two potential blockbuster products. OLDWICK, N.J., March 12, 2020 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a clinical-stage biopharmaceutical company dedicated to intercepting and...
Tailwinds' Take: very interesting that they have engaged two firms for partnership efforts, first in China, now Japan. We continue to believe that this platform has blockbuster potential. AUSTIN, Texas--(BUSINESS WIRE)-- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on...
INmune Bio, Inc. Fourth Quarter and Full Year 2019 Earnings Call March 11, 2020, 11 AM  Presenters Landon Baretto, Moderator Raymond J. Tesi, MD, CEO David J. Moss, CFO Q&A Participants John Aschoff, Roth Capital Markets Swayampakula Ramakanth, H.C. Wainwright Carl Byrnes, Northland Securities Daniel Carlson, Tailwinds...
Tailwinds' Take: this is the third supply agreement announced in the last week by Imprimis, Harrow's wholly owned subsidiary. Between the three agreements, they now cover 250,000 more annual surgeries than they did last week. With the market size...
•Company Sees No Negative Impact from Coronavirus •Reports Record Enrollment in March 2020 (month to date) •Full Year Revenue of $35.1 Million, Achieving Revenue Guidance and Up 131% from 2018 •Q4 2019 Record Quarterly Revenue of $11.8 Million, Up 109% Year over...
THE COLONY, Texas, March 12, 2020 (GLOBE NEWSWIRE) -- Quest Resource Holding Corporation (NASDAQ: QRHC) ("Quest"), a national leader in environmental reuse, recycling, and waste disposal services, today announced financial results for the fourth quarter and year ended December...
Tailwinds' Take: Harrow continues to build a powerhouse in the compounding business with major upside from their subsidiaries. This is a long-term multi-year hold for Tailwinds. NASHVILLE, Tenn., March 13, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today...
Santa Monica, CA – March 12, 2020 – Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), an AI and telehealth enabled, virtualized outpatient healthcare treatment company, today reported its financial results for the fourth quarter and year ended December...
Sometimes a typo can hit the sweet spot, right? When I got the text that we're entering a beer market...well, let's just say that I couldn't have agreed more. Stocks are in free-fall, the country is entering a national...
Tailwinds' Take: 20% sequential growth in light of COVID-19 impact is outstanding. HyreCar is very well positioned to continue growing at a strong pace as things return to normal in the US. HyreCar Inc. (Nasdaq: HYRE), the carsharing marketplace for...
Tailwinds' Take: more product adoption. Standard becoming de facto for the industry. Sales follow design wins and there have been a lot of those. SAN JOSE, Calif.--(BUSINESS WIRE)-- WiSA® LLC, the Wireless Speaker and Audio Association, comprised of over 60 leading...
Tailwinds' Take: 2019 was a very impressive year of accomplishment for FBIO. The stage is set for a big 2020 as well, with many catalysts coming. The balance sheet and earnings can be confusing due to consolidation of subsidiaries,...
Tailwinds' Take: as companies grow, it's natural progression to bring in leaders with experience at larger organizations. LaVerne's background is a natural for the next stage of Catasys' growth. Particularly as I believe we are going to see them...
Tailwinds' Take: announcing a share repurchase demonstrates management's confidence in the current business and the strength of the balance sheet. We believe this will likely put a floor in the stock from which it can build. LUXEMBOURG and NEW YORK,...
Tailwinds' Take: very shrewd move by management to keep their traffic coming during a difficult environment. We believe that this management team is one of the best in this category and recent press releases prove this. Burleson, Texas, March 18,...
Tailwinds' Take: Voriconazole is a generic liquid or tablet that is ingested for diseases like IPA, which start in the lungs. Having a direct to the lung inhalation would be more effective and also reduce the dosage required. This...
Another great week in the market. The economy is in free-fall, unemployment is skyrocketing and stocks can't stop going up. How is this possible? Well, as many savvy investors have repeated numerous times over the years, don't fight the...
Normally I love my Saturday mornings. This is when I write the weekly newsletter and it gives me a chance to review the prior week in the market and look for meaningful insight into our companies and what investors...
SAN JOSE, Calif.--(BUSINESS WIRE)-- Summit Wireless Technologies, Inc. (Nasdaq: WISA), a leading provider of immersive, wireless sound technology for intelligent devices and next-generation home entertainment systems, today announced the sale of a $2.04 million senior secured security and warrant...
Tailwinds' Take: management has positioned GRIL perfectly for the current environment and is doing all the right things to set the company up for growth when things return to normal in the US. This is a very well run...
Tailwinds' Take: 500 enrollments per week annualizes at $150M in revenue. Numbers for Q1 are going to be beaten and Q2 numbers will have to be raised. This also puts the 2020 target of $90M well within reach even...
Tailwinds' Take: the CoronaVirus is having an impact here, but it's much more muted than for the other ridesharing companies, Uber and Lyft. Meanwhile, higher unemployment will likely lead to more drivers approaching the platform. Near term outlook is...
Tailwinds' Take: we are very enthusiastic about the growth of the platform. The standard makes sense to us and it's good to see that the A/V community is rapidly picking up on it. This is a big transition year...
NASHVILLE, Tenn., March 24, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) and ImprimisRx, the nation’s leading ophthalmic-focused outsourcing facility and pharmaceutical compounding business, a wholly-owned subsidiary of Harrow, announced that they have entered into an exclusive agreement...
AUSTIN, Texas--(BUSINESS WIRE)--Mar. 26, 2020-- TFF Pharmaceuticals, Inc. (NASDAQ:TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today reported financial results for the fourth quarter and full...
When 2019 came to a close, the economy was humming and many companies were seeing strong business trends. How quickly it all comes crashing down, right? The CoronaVirus has slammed the brakes on the economy, to the detriment of...
My Take on The Market This was a good week in the market, which was a welcome relief. We had a big bailout announced by the federal government and some estimates of how bad COVID19 could be came down a...
Tailwinds' Take: continued expansion within their protected niche market of military bases continues to drive growth here. Management is executing on their stated strategy. Burleson, Texas, Mar. 30th, 2020 - Muscle Maker, Inc. (NASDAQ: GRIL) the parent company of Muscle...
Here's an interesting piece of news on Patriot One (PTOTF). If you recall, a little over a year ago, Patriot formed a JV to "commercialize a technology for the stand-off detection of explosives and other threats such as chemical...
Tailwinds' Take: nice to see Samsung's subsidiary, Harman Kardon, rolling out more products. They obviously believe this is the future and must be seeing demand to increase product lines. If parent company Samsung ever gets on board, WISA will...
Tailwinds' Take: although PRVB remains one of my larger holdings, I haven't written much about it lately. That's because we're really in a holding period, waiting for the big news which is the submission of a BLA which should...
Tailwinds' Take: MTBC is a well run organization that is pursuing a rational growth strategy. These additions will add to that growth over time. We remain very positive on MTBC's future. SOMERSET, N.J., April 01, 2020 (GLOBE NEWSWIRE) -- MTBC,...
In this, our third article about Fortress Biotech (FBIO), we discuss the value of two in-house subsidiaries, Journey Medical and Caelum BioSciences. Both entities have unique aspects which add considerably to the value of the parent company. Our prior two...
~ Trade alerts discuss changes to Tailwinds' managed portfolios. They are available for premium subscribers only. The information contained here is not meant to be shared, especially with Company managements. Thank you. ~ I'm in the process of positioning myself...
My biggest concern last fall was, "what if Bernie gets into office?" This fear was driven partially by the fact that the market would likely sell off with the democratic socialist in charge, but more so by the concern...
Tailwinds' Take: HYRE appears to be surviving the CV19 crisis and will be well-positioned when the country opens back up for business. Continue to believe at this price there's great value here. LOS ANGELES--(BUSINESS WIRE)--HyreCar Inc. (NASDAQ: HYRE), the carsharing...
It was certainly a great week for the market as a number of positive factors contributed to the continuation of what is a very big rally from the recent lows. The news flow around CV19 (hospitalizations appear to be...
Tailwinds' Take: CATS is getting closer to national coverage with Aetna. We are still awaiting a national rollout with another insurance carrier (UNH?), which we hope will be announced soon. Santa Monica, CA - April 7, 2020 - Catasys, Inc....
Tailwinds' Research: necessary step to staying on Nasdaq. Please, just get the financing over so we can get this going in the right direction finally. SAN JOSE, Calif.--(BUSINESS WIRE)-- Summit Wireless Technologies, Inc. (NASDAQ: WISA), a leading provider of immersive, wireless sound...
Tailwinds' Take: a positive step towards approval of this needed therapy. Fortress Bio (FBIO), the parent of Mustang, has many such catalysts going forward and remains a top pick of Tailwinds. NEW YORK, April 20, 2020 (GLOBE NEWSWIRE) -- Mustang...
SOMERSET, N.J., April 09, 2020 (GLOBE NEWSWIRE) -- MTBC, Inc. (Nasdaq: MTBC) (Nasdaq: MTBCP), a leading provider of cloud-based healthcare IT solutions and services, including telehealth, reaffirmed its 2020 revenue and earnings guidance, which will represent year-over-year revenue and adjusted EBITDA...
GOLETA, Calif., April 14, 2020 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for mobile handset and wireless devices, today announced expanded performance for...
TORONTO, ON (GLOBE NEWSWIRE – April 13, 2020) – Patriot One Technologies Inc. (TSX: PAT) (OTCQX: PTOTF) (FRANKFURT: 0PL) (“Patriot One” or the “Company”), is pleased to announce it has hired technology industry veteran Dietmar Wennemer as the Company’s new Chief...
SOMERSET, N.J., April 14, 2020 (GLOBE NEWSWIRE) -- MTBC, Inc. (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of cloud-based healthcare IT solutions and services, today announced it has been selected by Titan Health Management Solutions (Titan Health) to support the company’s rapidly expanding...
Tailwinds' Take: once again, we believe this is a VERY smart management team and this is a very shrewd move. It's tough in the restaurant industry, but these guys will come out the tail end of the CV lockdown...
Tailwinds' Take: this quote from CEO Mattes says it all, “This CRADA, with the world’s preeminent biodefense research organization, is another validation of Thin Film Freezing’s potential as an important, disruptive platform technology.” Tailwinds believes the platform will be...
Tailwinds' Take: nice to see that everything remains on track for PRVB. We expect to see the filing completed by year-end with PDUFA date in the first half of 2021. Tough to see the stock not dramatically higher once...
Tailwinds' Take: this Phase II trial is going to happen quickly. Inflammation is a big part of the problems associated with CV19 and INmune's DN-TNF platform could be ideally positioned to be a part of saving lives. We are...
Tailwinds' Take: with TruNiagen being OTC, one could see this type of report creating a viral sensation for the supplement. This is potentially very big news for investors. LOS ANGELES--(BUSINESS WIRE)-- ChromaDex Corp. (NASDAQ:CDXC), a global scientific authority on nicotinamide...
Monday morning, INmune Bio (INMB) announced that they were pursuing a clinical program to determine if the Company’s TNF Inhibitor (DN-TNF) platform could help prevent complications of cytokine storm caused by COVID-19. This is potentially a breakthrough therapy for...
Tailwinds' Take: funding comes at a very expensive price in the current market. This deal certainly helps Summit position themselves for the future and we can only hope this is the absolute low in terms of valuation for the...
INmune Bio DN-TNF Clinical Trial, Complications of Cytokine Storm Caused by COVID-19 April 20, 2020 Presenter R.J. Tesi, CEO and Chief Medical Officer David Moss, CFO Q&A Participants John Aschoff - Roth Capital Michael Carmia - BTIG Jason McCarthy - Maxim Group Mikal Kaiser - BTIG R.K. - H.C. Wainwright Carl...
Tailwinds' Take: patents show the uniqueness of INKmune, which is set to start two clinical trials this year. INMB is one of the most exciting opportunities we see in the marketplace. LA JOLLA, Calif., April 22, 2020 (GLOBE NEWSWIRE) --...
Tailwinds' Take: this is a good move by the Company to refute the allegations by the short seller. I look forward to seeing the results of the investigation. I've personally been able to refute several of the accusations myself,...
Tailwinds' Take: FBIO owns ~30% of Avenue. This news, while not unexpected, further cements the case for IV Tramadol being a well-used medication post approval. We expect the acquisition of ATXI to close this year and believe the Contingent...
Tailwinds' Take: more evidence on the negative role that soluble TNF plays in many diseases. INMB's ability to neutralize soluble TNF without associated immuno-supression makes them a potential part of the therapy not only in breast cancer, but other...
Tailwinds' Take: being able to distinguish men who are disease free could dramatically reduce the number of unnecessary biopsies performed annually, resulting in both fewer painful surgeries for patients and large savings for the medical system. SAN JOSE, Calif., April...
CoronaVirus is not only the buzzword for the whole market both on the negative side as business falls off a cliff, and positively as some companies look for a cure. It seems like most everyone in healthcare is looking...
Tailwinds' Take: CoronaVirus has given investors another chance here as this story seems only slightly delayed. Things are about to get very interesting at Vicor. The next twelve months look very exciting. ANDOVER, Mass., April 23, 2020 (GLOBE NEWSWIRE) --...
While the markets may not have had the most volatile week of the year, nor come close, it was a very topsy-turvy five days for Tailwinds. A couple stocks up over 30% and a couple down over 50%. Meanwhile,...
GOLETA, Calif., May 06, 2020 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for mobile handset and wireless devices, today announced financial results for...
NEW YORK, May 06, 2020 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company focused on the acquisition, development and commercialization of novel treatments for patients with solid tumor cancers, today announced...
Well, I've been expecting it and it appears that it's here. The market put up one of its best months ever in April, but starting on Thursday my anticipated end of the rally kicked off. I'm saying it here...
Tailwinds' Take: more solid results. Once the company right-sizes the balance sheet, they will be very well positioned. IRVINE, CA / ACCESSWIRE / April 28, 2020 / Hancock Jaffe Laboratories, Inc. (HJLI)(HJLIW), a developer of medical devices that restore cardiac and vascular health,...
Tailwinds' Take: MTBC restocks their war chest as they start looking for their next acquisition. The team here are thoughtful and deliberate. The execution to date has been spot-on. As they move over $100M in revenues, the stock could...
Tailwinds' Take: Hancock Jaffe needs to have a decent sized financing to right-size the balance sheet and get the stock moving. These band-aids are painful as they just drip feed the Company. IRVINE, CA / ACCESSWIRE / April 27, 2020 /...
TORONTO, ON (April 29, 2020) – Patriot One Technologies Inc. (TSX: PAT) (OTCQX: PTOTF) (FRANKFURT: 0PL) (“Patriot One” or the “Company”), maker of the PATSCAN Multi-Sensor Covert Threat Detection Platform, today announced it has joined the NVIDIA Metropolis Software Partner Program. The NVIDIA Metropolis...
Tailwinds' Take: this is potentially huge news. This quote, "Niclosamide has been shown to be considerably more potent when compared with other drugs such as chloroquine, lopinavir and remdesivir against COVID-19, and because of its activity as an antiviral...
Tailwinds' Take: today's ruling demonstrates that Qualcomm will not be able to run right over Parkervision in their ongoing patent infringement cases. PRKR has recruited a top-notch legal team who are all working on success fees, which speaks not...
LOS GATOS, Calif. , April 30, 2020 (GLOBE NEWSWIRE) -- Atomera Incorporated (NASDAQ: ATOM), a semiconductor materials and intellectual property licensing company focused on deploying its proprietary technology into the semiconductor industry, today provided a corporate update and announced financial results for the first...
As COVID-19 shuts down a large swath of the economy and makes working remotely the global standard, I touched base with Martin Cronin to see how Patriot One was faring during the shutdown. It was a very fruitful call...
Tailwinds' Take: this selection of a therapeutic candidate has happened very quickly and demonstrates the powerful potential of Dr. Kumar's teams' A.I. expertise combined with OntoChem's platform of molecular candidates. We look forward to frequent updates on the program...
ATOM - Q1 2020 Atomera Inc Earnings Call C O R P O R A T E  P A R T I C I P A N T S Francis Laurencio Atomera Incorporated - Chief Financial & Accounting Officer and Corporate...
SOMERSET, N.J, May 05, 2020 (GLOBE NEWSWIRE) -- MTBC, Inc. (Nasdaq: MTBC) (Nasdaq: MTBCP), a leading provider of cloud-based healthcare IT solutions and services, today announced MDS Medical, LLC (MDS), a national healthcare information technology and medical billing services vendor, has...
Tailwinds' Take: Continued execution by this team. As the country begins to open up, GRIL is well positioned for growth and the valuation is very cheap. Burleson, Texas, May 6th, 2020 - Muscle Maker Grill, Inc. (Nasdaq: GRIL) the parent...
The market continues to ignore my bearish calls and, instead, keeps chugging higher. I'm at a loss to explain this, as are most professional investors with whom I speak. Here in my home of Marin County, we expect restaurants...
Tailwinds' Take: all systems go for tepluzimab. We expect the stock to continue performing well as the company gets closer to the anticipated approval and subsequent launch of their groundbreaking T1D treatment. OLDWICK, N.J., May 7, 2020 /PRNewswire/ -- Provention...
DEER PARK, Ill., May 07, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today disclosed that it has been confirmed as the first filer of an Abbreviated New Drug Application (ANDA)...
Tailwinds' Take: enrollment continues to ramp quickly. Stock remains undervalued relative to the growth rate and level of business when compared to peers. SANTA MONICA, Calif.--(BUSINESS WIRE)-- Catasys, Inc. (CATS) (“Catasys” or the “Company”), an AI and telehealth enabled, virtualized...
Tailwinds' Take: this is another potential coup by Fortress, as their business model involves partnering on and developing novel therapies. Their ability to create value for shareholders while bringing new drugs to market presents investors with many potentially positive...
~ Trade alerts discuss changes to Tailwinds' managed portfolios. They are available for premium subscribers only. The information contained here is not meant to be shared, especially with Company managements. Thank you. ~ I bought back into Summit Wireless (WISA)...
As the country begins to open up again, we figured it was timely to touch base with HyreCar (HYRE). Our last conversation had left us thinking that, although COVID-19 lockdowns were certainly a negative for their near-term business, the...
Tailwinds' Take: further evidence of the broad-scale applications possible by reducing soluble TNF and associated inflammation. INB03 has the potential to be used in multiple therapies beyond oncology, including Nash, Alzheimers and COVID-19. LA JOLLA, Calif., May 11, 2020 (GLOBE...
Tailwinds' Take: Fortress has a whole host of catalysts coming during 2020, as detailed in this shareholder update. Importantly, by breaking out the non-GAAP numbers, a path to cash-flow positive is detailed. Once Journey resumes rapid growth (post-Covid), we...
Tailwinds' Take: more geographic expansion as Catasys' OnTrak program drives returns for this insurer. Enrollment momentum continuing and further expansions expected. The future continues to be very bright for CATS. Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI-powered and...
Tailwinds' Take: ChromaDex appears to be hitting their stride. New markets are opening and ongoing clinical studies should keep interest high. If they show any efficacy in reducing the effects of CV19, sales could really launch. First Quarter 2020 Highlights...
To the Stockholders of Harrow Health, Inc, I’ll start by conveying our sincerest wishes of good health. Thankfully, our most valuable assets, our employees in California, New Jersey, Tennessee and those that are field based, have remained healthy and continued...
Tailwinds' Take: while it's unfortunate that the company raised money prior to a license agreement, COVID-19 issues have pushed those signings out slightly. We view this news as a positive overall in that they have taken financing risk off...
IRVINE, CA / ACCESSWIRE / May 12, 2020 / Hancock Jaffe Laboratories, Inc. (HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that the Company has received approval from the Superintendent of Health of the National...
WESTON, FL – May 13, 2020 – Monaker Group, Inc. (NASDAQ: MKGI), a technology leader in the travel and vacation rental markets, has launched the new Maupintour.com website, re-energizing the historic 70 year-old tour company with technology for post-pandemic...
Tailwinds' Take: submitting an IND for Covid-19 this month is the biggest potential near term driver, but there are lots of shots on goal here for a small company. Next up after this is a peek at interim Alzheimer's...
Tailwinds' Take: continued execution by MTBC as they maintain guidance for outstanding growth. Very well run company that trades at a reasonable valuation and has the opportunity to continue being a consolidator in a fragmented industry. SOMERSET, N.J., May 14,...
AUSTIN, Texas--(BUSINESS WIRE)--May 14, 2020--TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today reported financial results for the first quarter ended March...
THE COLONY, Texas, May 14, 2020 (GLOBE NEWSWIRE) -- Quest Resource Holding Corporation (NASDAQ: QRHC) ("Quest"), a national leader in environmental waste and recycling services, today announced financial results for the first quarter ended March 31, 2020. First Quarter 2020...
LOS ANGELES--(BUSINESS WIRE)--HyreCar Inc. (NASDAQ: HYRE), the carsharing marketplace for ridesharing and delivery, today reported financial results and provided a corporate update for the first quarter ended March 31, 2020. “HyreCar’s first quarter revenues grew 20% sequentially to $5.8 million...